Dr. Afshin Dowlati, MD
Claim this profileUniversity Hospitals Cleveland Medical Center
Studies Tumors
Studies Non-Small Cell Lung Cancer
15 reported clinical trials
29 drugs studied
Area of expertise
1Tumors
Stage IV
Stage III
HER2 negative
2Non-Small Cell Lung Cancer
Stage IV
Stage III
HER2 negative
Affiliated Hospitals
Clinical Trials Afshin Dowlati, MD is currently running
2X-121 + Dovitinib
for Cancer
This is a Phase Ib, two-part, multi-center study. In Part 1, the study will evaluate the safety and tolerability, antitumor activity, pharmacokinetics, and determine the maximum tolerated dose (MTD) of 2X-121 monotherapy (at BID regimen) in patients with advanced solid tumors. In Part 2, the study will evaluate safety and tolerability, antitumor activity, pharmacokinetics and determine the MTD of dovitinib when given in combination with the MTD of 2X-121 determined in Part 1.
Recruiting1 award Phase 1
GD2-SADA:177Lu-DOTA Complex
for Small Cell Lung Cancer
This trial tests a new treatment for certain cancers using a two-part method. The first part finds and attaches to cancer cells, and the second part delivers radiation to kill them. It aims to see if this treatment is safe and can be tolerated by patients with Small Cell Lung Cancer, Sarcoma, and Malignant Melanoma.
Recruiting1 award Phase 19 criteria
More about Afshin Dowlati, MD
Clinical Trial Related5 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Afshin Dowlati, MD has experience with
- Nivolumab
- Carboplatin
- Etoposide
- SGN-CD228A
- Atezolizumab
- HPN328
Breakdown of trials Afshin Dowlati, MD has run
Tumors
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Afshin Dowlati, MD specialize in?
Afshin Dowlati, MD focuses on Tumors and Non-Small Cell Lung Cancer. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are Stage III.
Is Afshin Dowlati, MD currently recruiting for clinical trials?
Yes, Afshin Dowlati, MD is currently recruiting for 8 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Afshin Dowlati, MD has studied deeply?
Yes, Afshin Dowlati, MD has studied treatments such as Nivolumab, Carboplatin, Etoposide.
What is the best way to schedule an appointment with Afshin Dowlati, MD?
Apply for one of the trials that Afshin Dowlati, MD is conducting.
What is the office address of Afshin Dowlati, MD?
The office of Afshin Dowlati, MD is located at: University Hospitals Cleveland Medical Center, Cleveland, Ohio 44106 United States. This is the address for their practice at the University Hospitals Cleveland Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.